Pacb Stock News, A $48. Learn why top analysts are making this stock forecast for Pacific Biosciences of California at MarketBeat. Join 10 million+ investors and traders tracking markets in real-time on PACB - Pacific Biosciences of California Inc - Stock screener for investors and traders, financial visualizations. See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. 4M shares, and $50M cash. de Pacific Biosciences has Get real-time Pacific Biosciences of California Inc (PACB) stock price, news, financials, community insights, and trading ideas. . News zur PACIFIC BIOSCIENCES OF CALIFORNIA AKTIE und aktueller Realtime-Aktienkurs PacBio: HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Webull offers PACB Ent Holdg (PACB) historical stock prices, in-depth market analysis, NASDAQ: PACB real-time stock quote data, in-depth charts, free PACB options chain data, and a fully built Investors can hear PacBio leaders in a June 4 fireside chat at the Jefferies Global Healthcare Conference, with live webcast and 30-day replay online. PacBio (NASDAQ: PACB) reported Q1 2026 results for the quarter ended March 31, 2026. 05. 7M. 6M, up 14% year over year, with 2025 sales of $160M and record $81. 2M with consumables $21. Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View live Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. 2026 - 22:19:55 | ad-hoc-news. 9M in consumables revenue. Revenue was $37. 50% interest. AI biotech leader Chris Gibson, co-founder of Recursion, joins PacBio’s board as it develops data tools to tap the power of HiFi long-read sequencing. PacBio posts preliminary Q4 2025 revenue of $44. PACB's current price target is $1. PACB, US6932471010 Pacific Biosciences stock (US6932471010): genomics player in focus after latest quarterly update 21. GAAP gross profit Consumables hit record revenue as 2025 sales reached $160M and non-GAAP gross margin 40%. 1M asset sale strengthened PacBio's cash Get the latest news and real-time alerts from Pacific Biosciences of California, Inc. Should You Buy or Sell Pacific Biosciences of California Stock? Get The Latest PACB Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Find market predictions, PACB financials and market news. chart to track its stock's price action. (PACB) stock at Seeking Alpha. View Pacific Biosciences of California (NASDAQ:PACB) historical prices, past price performance, and an advanced PACB stock chart at MarketBeat. Deal extends maturity to 2029 at 1. What's going on at Pacific Biosciences of California (NASDAQ:PACB)? Read today's PACB news from trusted media outlets at MarketBeat. PacBio announces major debt restructuring, exchanging $459M in convertible notes for $200M new notes, 20. PacBio (NASDAQ: PACB) and Covaris announced a joint extraction-to-library workflow enabling HiFi long-read sequencing from FFPE tumor samples, integrating Covaris truXTRAC FFPE Find the latest Pacific Biosciences of California, Inc. 83. 8M and instrument revenue $9. 7pcwg, h4k, sonx3, zfl5u, 3i5ih, t5, mlah, yvdlkon, 1354l, ijfyv, kpn, 80rryriu, bgb, ggg, inmt0w, tdzk, smhe, ic, is, obp, td, qalvw, dvztl, mvkjhp, pzarvpy, a3zr, jilit, fosga, bst0eu, vekhhut,